French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia ; volume:1 ; number:1 ; day:10 ; month:12 ; year:2012 ; pages:1-8 ; date:12.2012
Experimental hematology & oncology ; 1, Heft 1 (10.12.2012), 1-8, 12.2012
- Urheber
-
Trioche, Pascale
Nelken, Brigitte
Michel, Gérard
Pellier, Isabelle
Petit, Arnaud
Bertrand, Yves
Rohrlich, Pierre
Schmitt, Claudine
Sirvent, Nicolas
Boutard, Patrick
Margueritte, Geneviève
Pautard, Brigitte
Ducassou, Stéphane
Plantaz, Dominique
Robert, Alain
Thomas, Caroline
Desseaux, Kristell
Chevret, Sylvie
Baruchel, André
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/2162-3619-1-39
- URN
-
urn:nbn:de:101:1-2019090304442492901906
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Trioche, Pascale
- Nelken, Brigitte
- Michel, Gérard
- Pellier, Isabelle
- Petit, Arnaud
- Bertrand, Yves
- Rohrlich, Pierre
- Schmitt, Claudine
- Sirvent, Nicolas
- Boutard, Patrick
- Margueritte, Geneviève
- Pautard, Brigitte
- Ducassou, Stéphane
- Plantaz, Dominique
- Robert, Alain
- Thomas, Caroline
- Desseaux, Kristell
- Chevret, Sylvie
- Baruchel, André
- SpringerLink (Online service)
Ähnliche Objekte (12)
Testicular leukaemic infiltration in relapsed acute lymphoblastic leukaemia: a case report
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
Loss of CD22 expression and expansion of a CD22dim subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults
Cost-Effectiveness of Inotuzumab Ozogamicin Compared to Standard of Care Chemotherapy for Treating Relapsed or Refractory Acute Lymphoblastic Leukaemia Patients in Norway and Sweden
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain
Uncommon manifestations of acute lymphoblastic leukaemia (ALL)
Testicular leukaemic infiltration in relapsed acute lymphoblastic leukaemia: a case report
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
Loss of CD22 expression and expansion of a CD22dim subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults
Cost-Effectiveness of Inotuzumab Ozogamicin Compared to Standard of Care Chemotherapy for Treating Relapsed or Refractory Acute Lymphoblastic Leukaemia Patients in Norway and Sweden
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain
Uncommon manifestations of acute lymphoblastic leukaemia (ALL)
Testicular leukaemic infiltration in relapsed acute lymphoblastic leukaemia: a case report
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
Loss of CD22 expression and expansion of a CD22dim subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults
Cost-Effectiveness of Inotuzumab Ozogamicin Compared to Standard of Care Chemotherapy for Treating Relapsed or Refractory Acute Lymphoblastic Leukaemia Patients in Norway and Sweden
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain